Clinical Trials Browser

Phase 2 × Glutamine × Plasma cell × Clear all

NCT01783522 2019-10-22

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Phase 2 Terminated

9 enrolled 10 charts

Multiple Myeloma, Peripheral Nervous System Diseases

NCT02114502 2014-07-11

Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell